Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-10-23
2009-06-30
McIntosh, III, Traviss C (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S062000, C536S018700, C536S022100
Reexamination Certificate
active
07553820
ABSTRACT:
This invention provides compounds having excellent antitumor activity, which are represented by the following formulaein which R1, R2, R3, m, n and R4have the significations as given in the specification.
REFERENCES:
patent: 2002/0086041 (2002-07-01), Maignan et al.
patent: 2004/0053288 (2004-03-01), Yanai et al.
patent: 0091694 (1983-10-01), None
patent: 0534546 (1993-03-01), None
patent: 0670317 (1995-09-01), None
patent: 09-40687 (1997-02-01), None
patent: 95/33847 (1995-12-01), None
International Search Report mailed Apr. 8, 2003 in the International (PCT) Application of which the grandparent application is the U.S. National Stage.
McIntosh, III Traviss C
Ohgen Research Laboratories Ltd.
Wenderoth Lind & Ponack, LLP.
LandOfFree
Mevalonic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mevalonic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mevalonic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4091301